ISPOR 11th Annual International Meeting
May 20-24, 2006  Marriott Philadelphia, Philadelphia, PA
 

RELEASED PRESENTATIONS


The ISPOR RESEARCH DIGEST is an electronic database of research papers presented at ISPOR Annual International Meetings, ISPOR Annual European Congresses, ISPOR Asia-Pacific and Latin America Conferences from 1998 to date. See: ISPOR Research Digest for contributed research podium and poster abstracts and released slide or poster presentations.
FIRST PLENARY SESSION
BALANCING AFFORDABILITY AND VALUE: THE UNIVERSAL CHALLENGE IN HEALTH CARE DELIVERY
Leonard D. Schaeffer
Founding Chairman & CEO, WellPoint

BALANCING AFFORDABILITY AND VALUE: THE UNIVERSAL CHALLENGE IN HEALTH CARE DELIVERY OR Evidence Evidence-based Decision Making in an Era of Cost Containment
Marc L. Berger, MD
Vice President, Outcomes Research & Management, Merck & Co., Inc.
 

SECOND PLENARY SESSION
COMPARATIVE EFFECTIVENESS & HEALTH CARE DECISION-MAKING
Joseph DiCesare, MPH, RPh
Head, Health Economics & Outcomes Research, Novartis Pharmaceuticals Corp., East Hanover, NJ

EFFICIENCY, QUALITY AND COST IN HEALTH CARE
Harvey V. Fineberg , MD, PhD

President & Chair, Institute of Medicine, Washington, DC
 

THIRD PLENARY SESSION
THE PATIENT VOICE IN MEDICAL PRODUCT EVALUATION: FDA DRAFT GUIDANCE ON MEASURING PATIENT-REPORTED OUTCOMES
Laurie B Burke, RPh, MPH
Study Endpoints and Labeling, OND, CDER, FDA

THE PATIENT VOICE IN MEDICAL PRODUCT EVALUATION: FDA DRAFT GUIDANCE ON MEASURING PATIENT-REPORTED OUTCOMES - AN INDUSTRY PERSPECTIVE
Margaret L Rothman, PhD
Johnson & Johnson Pharmaceutical Services, LLC

ISPOR PRO SIG COMMENTS
Patrick Marquis, MD, MBA
Mapi Values, Boston

THE PATIENT VOICE IN MEDICAL PRODUCT EVALUATION: FDA DRAFT GUIDANCE ON MEASURING PATIENT-REPORTED OUTCOMES - COOPERATIVE SOLUTIONS
Nancy Kline Leidy PhD
Health Care Analytics Group, United BioSource Corporation



11th Annual Meeting Main Page